Allspring Global Investments
XBI icon

Allspring Global Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Allspring Global Investments’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.36M Sell
46,998
-24,540
-34% -$3.32M 0.01% 805
2026
Q1 		$9.2M Sell
71,538
-105,474
-60% -$13.2M 0.02% 713
2025
Q4 		$21.5M Sell
177,012
-65,126
-27% -$7.47M 0.03% 515
2025
Q3 		$24.3M Buy
242,138
+108,072
+81% +$9.73M 0.04% 496
2025
Q2 		$11.1M Sell
134,066
-7,535
-5% -$601K 0.02% 677
2025
Q1 		$11.5M Sell
141,601
-12,717
-8% -$1.14M 0.02% 670
2024
Q4 		$13.9M Sell
154,318
-9,142
-6% -$886K 0.02% 649
2024
Q3 		$16.1M Sell
163,460
-9,365
-5% -$920K 0.03% 624
2024
Q2 		$16M Sell
172,825
-10,202
-6% -$915K 0.03% 623
2024
Q1 		$17.4M Sell
183,027
-18,785
-9% -$1.74M 0.03% 595
2023
Q4 		$18M Buy
201,812
+20,734
+11% +$1.54M 0.03% 586
2023
Q3 		$13.2M Sell
181,078
-25,177
-12% -$2.01M 0.02% 667
2023
Q2 		$17.2M Buy
206,255
+1,167
+0.6% +$97.6K 0.03% 641
2023
Q1 		$15.6M Sell
205,088
-8,430
-4% -$699K 0.03% 668
2022
Q4 		$17.7M Buy
213,518
+8,363
+4% +$677K 0.03% 619
2022
Q3 		$16.3M Sell
205,155
-4,306
-2% -$363K 0.03% 615
2022
Q2 		$15.6M Buy
209,461
+34,568
+20% +$2.59M 0.03% 661
2022
Q1 		$15.7M Sell
174,893
-3,958
-2% -$366K 0.02% 743
2021
Q4 		$20M Buy
+178,851
New +$21.6M 0.02% 704

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Allspring Global Investments's XBI Position: Q2 2026 in Review

Allspring Global Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 34% in Q2 2026, selling an estimated $3.32M and leaving 46,998 shares worth $7.36M. The position accounts for 0.01% of the portfolio, ranked #805.

Allspring Global Investments first reported a position in XBI in Q4 2021 and has held it in 19 quarters since. The position peaked at $24.3M in Q3 2025. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Allspring Global Investments held 46,998 shares of State Street SPDR S&P Biotech ETF worth $7.36M as of Q2 2026.
  • Allspring Global Investments sold 24,540 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.32M.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #805 holding.
  • Allspring Global Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's State Street SPDR S&P Biotech ETF position peaked at $24.3M in Q3 2025.
  • 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.